169 related articles for article (PubMed ID: 4151493)
1. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
[No Abstract] [Full Text] [Related]
2. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
Meyer RF; Stratton CD; Hastings SG; Corey RM
J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
[No Abstract] [Full Text] [Related]
3. [Comparative studies of antihypertensive effects of several beta-blocking agents in conscious rats (author's transl)].
Ozawa H; Watanabe H; Chen CS
Nihon Yakurigaku Zasshi; 1978 Jan; 74(1):139-44. PubMed ID: 25230
[TBL] [Abstract][Full Text] [Related]
4. Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
Lee RJ; Dickerson DD; Fulmor IE; Goldberg ME
Proc Soc Exp Biol Med; 1978 Jun; 158(2):147-50. PubMed ID: 27818
[No Abstract] [Full Text] [Related]
5. Syntheses and beta-adrenergic blocking activities of carbostyril derivatives.
Tominaga M; Tone H; Nakagawa K; Takada K; Hoshino Y; Watanabe K
Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2166-81. PubMed ID: 6119165
[No Abstract] [Full Text] [Related]
6. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
[No Abstract] [Full Text] [Related]
7. Beta-Adrenergic blocking agents. 15. 1-Substituted ureidophenoxy-3-amino-2-propanols.
Smith LH
J Med Chem; 1977 May; 20(5):705-8. PubMed ID: 16137
[No Abstract] [Full Text] [Related]
8. [Synthesis of 5-(3-tert-butylamino-2-hydroxypropoxy)-8-hydroxy-3,4-dihydrocarbostyril hydrochloride and its beta-adrenergic blocking activity].
Uchida M; Tominaga M; Oka K; Tone H; Uno T
Yakugaku Zasshi; 1976 May; 96(5):571-7. PubMed ID: 9501
[No Abstract] [Full Text] [Related]
9. [(Arylcarbonyl)oxy]propanolamines. 1. Novel beta-blockers with ultrashort duration of action.
Kam ST; Matier WL; Mai KX; Barcelon-Yang C; Borgman RJ; O'Donnell JP; Stampfli HF; Sum CY; Anderson WG; Gorczynski RJ
J Med Chem; 1984 Aug; 27(8):1007-16. PubMed ID: 6146718
[TBL] [Abstract][Full Text] [Related]
10. beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols.
Smith LH; Tucker H
J Med Chem; 1977 Dec; 20(12):1653-6. PubMed ID: 22750
[TBL] [Abstract][Full Text] [Related]
11. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
Mouillé P; Cheymol G
C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
[No Abstract] [Full Text] [Related]
12. A new series of cardioselective adrenergic beta-receptor blocking compounds. 1-(2-Acyl-4-acylaminophenoxy)-3-isopropylaminopropan-2-ols.
Basil B; Clark JR; Coffee EC; Jordon R; Loveless AH; Pain DL; Wooldridge KR
J Med Chem; 1976 Mar; 19(3):399-402. PubMed ID: 3647
[TBL] [Abstract][Full Text] [Related]
13. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
Aellig WH
Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
[No Abstract] [Full Text] [Related]
14. 1-Alkylamino-3-(2-thiazolyloxy)-2-propanols. A novel class of mixed myocardial beta-stimulants-beta-blockers.
Edwards JA; Berkoz B; Lewis GS; Halpern O; Fried JH; Strosberg AM; Miller LM; Urich S; Liu F; Roszkowski AP
J Med Chem; 1974 Feb; 17(2):200-3. PubMed ID: 4148933
[No Abstract] [Full Text] [Related]
15. Cardiovascular beta-adrenergic receptor blocking activities of 1-(7-indenyloxy)-3-isopropyl-aminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
Kato H; Noguchi Y; Nakao K; Takagi K
Jpn J Pharmacol; 1974 Apr; 24(2):261-70. PubMed ID: 4152803
[No Abstract] [Full Text] [Related]
16. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic blockade by 3-[3-(substituted amino)-2-hydroxypropox]-5-hydroxybenzyl alcohols.
Schwender CF; Pike RE; Shavel J
J Med Chem; 1975 Feb; 18(2):211-3. PubMed ID: 235645
[No Abstract] [Full Text] [Related]
18. Beta-adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino)propan-2-ols.
Tucker H
J Med Chem; 1980 Oct; 23(10):1122-6. PubMed ID: 6106716
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of a novel series of (aryloxy)propanolamines: new selective beta 2-blocking agents.
Carre MC; Youlassani A; Caubere P; Saint-Aubin-Floch A; Blanc M; Advenier C
J Med Chem; 1984 Jun; 27(6):792-9. PubMed ID: 6145801
[TBL] [Abstract][Full Text] [Related]
20. Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols.
Condon ME; Cimarusti CM; Fox R; Narayanan VL; Reid J; Sundeen JE; Hauck FP
J Med Chem; 1978 Sep; 21(9):913-22. PubMed ID: 31485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
